{"id":3332,"date":"2024-04-26T17:30:19","date_gmt":"2024-04-26T14:30:19","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3332"},"modified":"2024-04-26T17:31:48","modified_gmt":"2024-04-26T14:31:48","slug":"boehringer-ingelheim-turkiye-en-iyi-isverenler-listesinde-yer-aldi","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3332","title":{"rendered":"Boehringer Ingelheim T\u00fcrkiye En \u0130yi \u0130\u015fverenler Listesinde Yer Ald\u0131"},"content":{"rendered":"\n

\u00d6nde gelen ara\u015ft\u0131rma odakl\u0131 bir ila\u00e7 \u015firketi olan Boehringer Ingelheim T\u00fcrkiye, \u00e7al\u0131\u015fan odakl\u0131 kurum k\u00fclt\u00fcr\u00fc do\u011frultusunda imza att\u0131\u011f\u0131 fark yaratan uygulamalar\u0131yla \u00f6nde gelen itibarl\u0131 kurulu\u015flar taraf\u0131ndan \u00f6d\u00fcllendirilmeye devam ediyor. Boehringer Ingelheim T\u00fcrkiye, Great Place To Work Enstit\u00fcs\u00fc’n\u00fcn a\u00e7\u0131klad\u0131\u011f\u0131 \u2018Y\u0131l\u0131n En \u0130yi \u0130\u015fverenleri\u2019 listesinde yerini alarak en iyi i\u015fverenlerden biri olarak se\u00e7ildi.<\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u201cNesiller Boyu Ya\u015famlar\u0131 D\u00f6n\u00fc\u015ft\u00fcrme\u201d hedefiyle, insan ve hayvan sa\u011fl\u0131\u011f\u0131 alanlar\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 tedaviler geli\u015ftiren Boehringer Ingelheim T\u00fcrkiye, \u00e7al\u0131\u015fanlar\u0131n\u0131n esenli\u011fini ve mutlulu\u011funu art\u0131rmaya y\u00f6nelik \u00e7al\u0131\u015fmalar\u0131yla\u00a0insan kaynaklar\u0131 alan\u0131nda \u00f6nde gelen kurulu\u015flar taraf\u0131ndan takdir edilmeye devam ediyor. Boehringer Ingelheim T\u00fcrkiye, son olarak i\u015fyeri k\u00fclt\u00fcr\u00fc ve \u00e7al\u0131\u015fan deneyimi konusunda uzman, k\u00fcresel bir organizasyon olan Great Place To Work Enstit\u00fcs\u00fc’n\u00fcn a\u00e7\u0131klad\u0131\u011f\u0131 \u2018Y\u0131l\u0131n En \u0130yi \u0130\u015fverenleri\u2019 listesinde yerini ald\u0131.\u00a0<\/p>\n\n\n\n

\u015eirket, \u00e7al\u0131\u015fan odakl\u0131 kurum k\u00fclt\u00fcr\u00fc do\u011frultusunda, hem \u00e7al\u0131\u015fanlar\u0131na \u00f6\u011frenme ve geli\u015fim ara\u00e7lar\u0131 sunan kurum k\u00fclt\u00fcr\u00fc hem de \u00e7al\u0131\u015fanlar\u0131na y\u00f6nelik i\u015f ve \u00f6zel hayat dengesini sa\u011flama ama\u00e7l\u0131 uygulamalar\u0131 ve kariyer geli\u015fim f\u0131rsatlar\u0131 ile \u00f6ne \u00e7\u0131k\u0131yor. <\/p>\n\n\n\n

Y\u0131l\u0131n en iyi i\u015fverenlerinden biri olarak se\u00e7ilmenin gururunu ya\u015fad\u0131klar\u0131n\u0131 vurgulayan Boehringer Ingelheim T\u00fcrkiye \u0130nsan Kaynaklar\u0131 Direkt\u00f6r\u00fc \u00d6zlem Kar, \u201cBoehringer Ingelheim T\u00fcrkiye olarak bu ba\u015far\u0131m\u0131z\u0131n temelinde; \u00f6zellikle \u00e7al\u0131\u015fanlar\u0131m\u0131za sundu\u011fumuz bireysel geli\u015fim planlar\u0131, kapsay\u0131c\u0131 \u00e7al\u0131\u015fma ortam\u0131m\u0131z, g\u00f6n\u00fcll\u00fcl\u00fck f\u0131rsatlar\u0131 ve ya\u015fam boyu \u00f6\u011frenme yakla\u015f\u0131m\u0131na katk\u0131da bulunan ba\u015far\u0131l\u0131 uygulamalar\u0131m\u0131z kilit rol oynuyor. \u015eirket olarak \u00f6ncelikle, sundu\u011fumuz pek \u00e7ok yenilik\u00e7i uygulama ile \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n i\u015f ve \u00f6zel hayatlar\u0131nda fark yaratmay\u0131 ama\u00e7l\u0131yoruz. Bu kapsamda bir\u00e7ok \u00f6nc\u00fc uygulamay\u0131 hayata ge\u00e7irmeye devam ediyoruz. Sekt\u00f6rdeki ilkler aras\u0131nda yer alan Bee Flexible\/ Esnek Yan Haklar sistemi, \u00e7al\u0131\u015fan dostu uygulamalar\u0131m\u0131z\u0131n ba\u015f\u0131nda gelirken, 2012 y\u0131l\u0131ndan bu yana, \u00e7al\u0131\u015fanlar\u0131m\u0131za yan haklar\u0131n\u0131 istedikleri gibi ki\u015fiselle\u015ftirme ve esnetme hakk\u0131 sunuyoruz. Ayr\u0131ca, \u00e7al\u0131\u015fanlar\u0131m\u0131za yasal izinlerine ek olarak, \u00e7al\u0131\u015fan mutlulu\u011fu ve esenli\u011fini art\u0131rmaya y\u00f6nelik olarak 10 g\u00fcnl\u00fck esenlik & i\u015f ya\u015fam dengesi izni veriyoruz. \u015eirket olarak ba\u015far\u0131m\u0131z\u0131n arkas\u0131ndaki en b\u00fcy\u00fck g\u00fcc\u00fcn i\u015fini tutkuyla yapan ve en \u00f6nemli ilham\u0131 \u2018yarat\u0131c\u0131l\u0131k ve geli\u015fim\u2019 olan \u00e7al\u0131\u015fanlar\u0131m\u0131z oldu\u011funu biliyoruz. Bu nedenle \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n bireysel ve kariyer geli\u015fimlerine katk\u0131 sunmak ve potansiyellerini ortaya koyacaklar\u0131 ideal \u00e7al\u0131\u015fma ortam\u0131n\u0131 sa\u011flamak en b\u00fcy\u00fck \u00f6nceli\u011fimiz. \u00c7al\u0131\u015fanlar\u0131m\u0131z\u0131n, \u015firketimizdeki tutkular\u0131n\u0131 ve mutluluklar\u0131n\u0131 s\u00fcrd\u00fcr\u00fclebilir k\u0131lmak ad\u0131na fark yaratan uygulamalar\u0131m\u0131z\u0131 s\u00fcrd\u00fcrece\u011fiz\u201d dedi.  <\/p>\n\n\n\n

 <\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"

\u00d6nde gelen ara\u015ft\u0131rma odakl\u0131 bir ila\u00e7 \u015firketi olan Boehringer Ingelheim T\u00fcrkiye, \u00e7al\u0131\u015fan odakl\u0131 kurum k\u00fclt\u00fcr\u00fc do\u011frultusunda imza att\u0131\u011f\u0131 fark yaratan uygulamalar\u0131yla \u00f6nde gelen itibarl\u0131 kurulu\u015flar taraf\u0131ndan \u00f6d\u00fcllendirilmeye devam ediyor. Boehringer Ingelheim T\u00fcrkiye, Great Place To Work Enstit\u00fcs\u00fc’n\u00fcn a\u00e7\u0131klad\u0131\u011f\u0131 \u2018Y\u0131l\u0131n En \u0130yi \u0130\u015fverenleri\u2019 listesinde yerini alarak en iyi i\u015fverenlerden biri olarak se\u00e7ildi<\/p>\n","protected":false},"author":1,"featured_media":3337,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3332"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3332"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3332\/revisions"}],"predecessor-version":[{"id":3335,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3332\/revisions\/3335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3337"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}